AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 2%
#96 out of 5020 analysts
Average Return
+13.62%
Win Rate
53%197 out of 369
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Cormedix IncCRMD | +230.33% | $3.33 | $11.00 | 2023-11-15 - 2024-11-14 | Buy |
Esperion Therapeutics IncESPR | +212.28% | $0.87 | $2.72 | 2025-05-07 - 2025-09-17 | Buy |
Cormedix IncCRMD | +209.65% | $3.42 | $10.59 | 2024-03-12 - 2025-03-11 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | 19 | Buy | $28.00 | +109.27% | Reiterates | 6 days ago |
Cytokinetics IncCYTK | 24 | Buy | $72.00 | +51.39% | Reiterates | 16 days ago |
Oculis Holding AgOCS | 1 | Buy | $36.00 | +106.90% | Initiates Coverage On | 22 days ago |
Amphastar Pharmaceuticals IncAMPH | 1 | Buy | $36.00 | +33.43% | Upgrades | a month ago |
Liquidia CorpLQDA | 32 | Buy | $36.00 | +44.00% | Maintains | a month ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +147.93% | Maintains | a month ago |
Trevi Therapeutics IncTRVI | 20 | Buy | $22.00 | +175.69% | Maintains | a month ago |
Arcutis Biotherapeutics IncARQT | 22 | Buy | $22.00 | +28.35% | Maintains | a month ago |
Viridian Therapeutics IncVRDN | 18 | Buy | $34.00 | +82.60% | Maintains | a month ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +237.42% | Downgrades | a month ago |
Ocular Therapeutix IncOCUL | 4 | Buy | $15.00 | +23.30% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 16 | Buy | $17.00 | +120.78% | Maintains | a month ago |
Clearside Biomedical IncCLSD | 16 | Hold | $45.00 | +1,146.54% | Downgrades | 2 months ago |
Cormedix IncCRMD | 18 | Buy | $20.00 | +79.86% | Maintains | 3 months ago |
Newamsterdam Pharma Co NvNAMS | 9 | Buy | $40.00 | +63.33% | Reiterates | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 12 | Buy | $66.00 | +28.96% | Reiterates | 4 months ago |
Xenon Pharmaceuticals IncXENE | 12 | Buy | $55.00 | +49.86% | Maintains | 4 months ago |
Pacira Biosciences IncPCRX | 27 | Buy | $30.00 | +15.07% | Maintains | 4 months ago |
Esperion Therapeutics IncESPR | 20 | Buy | $4.00 | +47.06% | Maintains | 4 months ago |
Collegium Pharmaceutical IncCOLL | 21 | Buy | $46.00 | +29.43% | Reiterates | 5 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | +2,621.09% | Downgrades | a year ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | a year ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 2 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.